Clinical Trial Update: Pimavanserin for the Treatment of Irritability Associated With Autism Spectrum Disorder [Phase 2, Phase 3]

View source ↗

Summary

The document reports the completion of Phase 2 and Phase 3 trials evaluating pimavanserin for irritability in autism spectrum disorder. Results have been posted…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Autism Spectrum Disorder

Drugs mentioned

• Pimavanserin (pimavanserin)

Snippet

Sponsor: ACADIA Pharmaceuticals Inc. | Conditions: Irritability Associated With Autism Spectrum Disorder | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2025-08-24